Krsnaa Diagnostics Ltd vs Metropolis Healthcare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Krsnaa Diagnostics Ltd is ₹ 497.75 as of 23 Oct 15:30 . The P/E Ratio of Krsnaa Diagnostics Ltd changed from 22.3 on March 2022 to 16.7 on March 2026 . This represents a CAGR of -5.62% over 5 yearsThe P/E Ratio of Metropolis Healthcare Ltd changed from 62.6 on March 2021 to 47.3 on March 2026 . This represents a CAGR of -4.56% over 6 years The Market Cap of Krsnaa Diagnostics Ltd changed from ₹ 1524 crore on March 2022 to ₹ 1690 crore on March 2026 . This represents a CAGR of 2.09% over 5 yearsThe Market Cap of Metropolis Healthcare Ltd changed from ₹ 11455 crore on March 2021 to ₹ 8992 crore on March 2026 . This represents a CAGR of -3.95% over 6 years The revenue of Krsnaa Diagnostics Ltd for the Jun '26 is ₹ 242.78 crore as compare to the Mar '26 revenue of ₹ 224.1 crore. This represent the growth of 8.34% The revenue of Metropolis Healthcare Ltd for the Jun '26 is ₹ 455.32 crore as compare to the Mar '26 revenue of ₹ 432.95 crore. This represent the growth of 5.17% The ebitda of Krsnaa Diagnostics Ltd for the Jun '26 is ₹ 65.23 crore as compare to the Mar '26 ebitda of ₹ 86.37 crore. This represent the decline of -24.48% The ebitda of Metropolis Healthcare Ltd for the Jun '26 is ₹ 116.3 crore as compare to the Mar '26 ebitda of ₹ 116.29 crore. This represent the growth of 0.01% The net profit of Krsnaa Diagnostics Ltd changed from ₹ 17.92 crore to ₹ 16.55 crore over 9 quarters. This represents a CAGR of -3.47% The net profit of Metropolis Healthcare Ltd changed from ₹ 38.11 crore to ₹ 56.88 crore over 9 quarters. This represents a CAGR of 19.48% The Dividend Payout of Krsnaa Diagnostics Ltd changed from 11.1 % on March 2022 to 6.32 % on March 2026 . This represents a CAGR of -10.65% over 5 yearsThe Dividend Payout of Metropolis Healthcare Ltd changed from 20.69 % on March 2021 to 65.83 % on March 2026 . This represents a CAGR of 21.28% over 6 years .

About Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Limited was originally incorporated as Krsna Diagnostics Private Limited' at Pune, Maharashtra dated December 22, 2010.
The Company name was changed to Krsnaa Diagnostics Private Limited', pursuant to a fresh Certificate of Incorporation issued by the RoC on January 29, 2015.
Thereafter, the status got converted into a Public Company and the name was changed to Krsnaa Diagnostics Limited pursuant to a fresh Certificate of Incorporation issued by the RoC on 06 May, 2021. The Company is primarily engaged in providing diagnostic services centres all over India.
The Company is providing Radiology and Pathology services for X-ray, CT Scan, MRI, Mammography, Bone Densitometry, Ultrasound, Colout Doppler, Tele-Reporting services, all type of blood and urine investigation and other related diagnostic services.

About Metropolis Healthcare Ltd

Dr. Sushil Kanubhai Shah, one of the Promoters, commenced pathology business in January 1980 as a partnership firm in the name of Dr. V. K. Desai's Hospital, having Dr. Kanubhai M. Shah, Dr. Sushil Kanubhai Shah and Dr. Vasant Kalyandas Desai as partners.
The partnership was continued by Dr. Sushil Kanubhai Shah, Dr. Kanubhai M. Shah and Dr. Duru Sushil Shah from September 30, 1981 onwards.
In June 1989, upon death of Dr. Kanubhai M. Shah, the partnership was continued by Dr. Sushil Kanubhai Shah and Dr. Duru Sushil Shah.
Prior to March 18, 1995, Dr. Sushil Kanubhai Shah was also carrying on a business of radioimmunoassay and pathology laboratory on a sole proprietorship basis.
On March 20, 1995, the said sole proprietorship business was converted into a partnership with Dr. Sushil Kanubhai Shah, Dr.

FAQs for the comparison of Krsnaa Diagnostics Ltd and Metropolis Healthcare Ltd

Which company has a larger market capitalization, Krsnaa Diagnostics Ltd or Metropolis Healthcare Ltd?

Market cap of Krsnaa Diagnostics Ltd is 1,614 Cr while Market cap of Metropolis Healthcare Ltd is 10,849 Cr

What are the key factors driving the stock performance of Krsnaa Diagnostics Ltd and Metropolis Healthcare Ltd?

The stock performance of Krsnaa Diagnostics Ltd and Metropolis Healthcare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Krsnaa Diagnostics Ltd and Metropolis Healthcare Ltd?

As of October 25, 2026, the Krsnaa Diagnostics Ltd stock price is INR ₹497.75. On the other hand, Metropolis Healthcare Ltd stock price is INR ₹522.95.

How do dividend payouts of Krsnaa Diagnostics Ltd and Metropolis Healthcare Ltd compare?

To compare the dividend payouts of Krsnaa Diagnostics Ltd and Metropolis Healthcare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.